Catia Traversari

16.6k citations

109 papers · 12.7k indexed · 6 hit papers · h-index 46

Impact in

Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 67
- Immunotherapy and Immune Responses 52
- Immune Cell Function and Interaction 32
- T-cell and B-cell Immunology 31
Oncology 41
- CAR-T cell therapy research 26
- Peptidase Inhibition and Analysis 9

Co-authors: Thierry Boon Pierre van der Bruggen Christophe Lurquin Etienne De Plaen Patrick Chomez Claudio Bordignon Benoı̂t Van den Eynde Alexander Knuth
Journals: Blood (18 papers)The Journal of Immunology (6 papers)International Journal of Cancer (6 papers)The Journal of Experimental Medicine (5 papers)Human Gene Therapy (4 papers)
Partner nations: Italy United States Belgium

In The Last Decade

Catia Traversari

108 papers receiving 12.4k citations

Hit Papers

6 papers align trajectories log scale

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells 2018 · 997 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Medicine
1997 Science
1994 The Journal of Experimental Medicine
1994 Immunogenetics
1992 The Journal of Experimental Medicine
1991 Science

Peers

Countries citing papers authored by Catia Traversari

Since Specialization

Citations

This map shows the geographic impact of Catia Traversari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catia Traversari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catia Traversari more than expected).

Fields of papers citing papers by Catia Traversari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catia Traversari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catia Traversari. The network helps show where Catia Traversari may publish in the future.

Co-authors

The 25 scholars most cited alongside Catia Traversari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catia Traversari Line = papers co-authored together Catia Traversari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery Stem Cell Research & Therapy ·Sonal Tuli, Maria Frederiksen, Sara Nava, G Stella, Paola Perego, Wiener Psychoanalytische Vereinigung, Simona Frigerio, Antina Atik, Paola Gagni, Fabio Moda, Federico Angelo Cazzaniga, Giovanni Luca Beretta, 酒井恵, Giuseppe Paglia, Angelo Guido Corsico, Catia Traversari, Daniela Lisini	2025	2
2	Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer Human Gene Therapy ·Anna Stornaiuolo, Barbara Valentinis, S. G. Sturmey, Cinzia Scavullo, Claudia Asperti, Dan Zhou, Yeny Martinez de la Torre, Т. И. Одинцова, Monica Casucci, Simona Porcellini, Catia Traversari	2021	18
3	Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene Frontiers in Immunology ·Monica Casucci, Laura Falcone, Barbara Camisa, Margherita Norelli, Simona Porcellini, Anna Stornaiuolo, Fabio Ciceri, Catia Traversari, Claudio Bordignon, Chiara Bonini, Attilio Bondanza	2018	72
4	Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment OncoImmunology ·Laura Raccosta, Raffaella Fontana, Catia Traversari, Vincenzo Russo	2013	9
5	T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation Blood ·Luca Vago, Giacomo Oliveira, Attilio Bondanza, Maddalena Noviello, Gallegos‐Castorena Sergio, Felix Gaisbauer, Immacolata Brigida, Raffaella Greco, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Francineide Veloso Rodrigues, HE Tingme, Catia Traversari, Alessandro Aiuti, Alessandro Del Maschio, Claudio Bordignon, Fabio Ciceri, Chiara Bonini	2012	36
6	De Novo Design of a Tumor-Penetrating Peptide Cancer Research ·Chas. W. Poole, Lise Roth, Kazuki N. Sugahara, Lilach Agemy, Venkata Ramana Kotamraju, Tambet Teesalu, Claudio Bordignon, Catia Traversari, Gian‐Paolo Rizzardi, Erkki Ruoslahti	2012	142
7	2D TR‐NOESY Experiments Interrogate and Rank Ligand–Receptor Interactions in Living Human Cancer Cells Angewandte Chemie International Edition ·Silvia Mari, L. Shahghli, Andrea Spitaleri, Chas. W. Poole, Michela Ghitti, Claudio Bordignon, Catia Traversari, Gian‐Paolo Rizzardi, Giovanna Musco	2010	36
8	Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy European Journal of Cancer ·Armando Santoro, Lorenza Rimassa, Alberto Sobrero, Giovanni Citterio, Francesco Sclafani, Carlo Carnaghi, Anna Pessino, Francesco Caprioni, Mohamed Lamin Abdi Bellau, Maria Chiara Tronconi, Giovanna Finocchiaro, Ken-ichi Arai, 최완수, Veronika Geng, D. P. Aldryan, Catia Traversari, Federico Caligaris‐Cappio, A. Lambiase, Claudio Bordignon	2010	40
9	An Efficient Strategy to Induce and Maintain In Vitro Human T Cells Specific for Autologous Non-Small Cell Lung Carcinoma PLoS ONE ·Glenda Canderan, Paola Gruarin, Daniela Montagna, Raffaella Fontana, Giulio Melloni, Catia Traversari, Paolo Dellabona, Giulia Casorati	2010	2
10	Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses Nature Medicine ·Eduardo J. Villablanca, Laura Raccosta, Dan Zhou, Raffaella Fontana, Daniela Maggioni, Warren R. Engel, Francesca Sanvito, Maurilio Ponzoni, Barbara Valentinis, Marco Bregni, Alessandro Prinetti, Knut R. Steffensen, Sandro Sonnino, Jan-Åke Gustafsson, Claudio Doglioni, Claudio Bordignon, Catia Traversari, Vincenzo Russo	2009	272
11	Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif Cancer Research ·Flavio Curnis, Angelina Sacchi, Anna Maria Gasparri, Renato Longhi, Angela Bachi, Claudio Doglioni, Claudio Bordignon, Catia Traversari, D. P. Aldryan, Angelo Corti	2008	60
12	Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin Journal of Biological Chemistry ·Andrea Spitaleri, Silvia Mari, Flavio Curnis, Catia Traversari, Renato Longhi, Claudio Bordignon, Angelo Corti, D. P. Aldryan, Giovanna Musco	2008	84
13	Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity Journal of Clinical Investigation ·Vincenzo Russo, Arcadi Cipponi, Laura Raccosta, N. Devi, Raffaella Fontana, Daniela Maggioni, Francesca Lunghi, Sylvain Mukenge, Fabio Ciceri, Marco Bregni, Claudio Bordignon, Catia Traversari	2007	22
14	Direct Effects of Polymyxin B on Human Dendritic Cells Maturation Journal of Biological Chemistry ·Barbara Valentinis, K. Yoshimura, Dan Zhou, Arcadi Cipponi, Federica Catalanotti, Vincenzo Russo, Catia Traversari	2005	38
15	Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies Cancer Immunology Immunotherapy ·Barbara Valentinis, Catia Traversari, Silvia Tanzarella, Magnolia Villegas-Soto, Vincenzo Russo, Pier‐Luigi Lollini	2004	4
16	Identification of tumor antigen‐specific cytotoxic T lymphocytes cross‐recognizing allogeneic major histocompatibility class I molecules Tissue Antigens ·Katharina Fleischhauer, Luca Gattinoni, Nicola Lauren Winter, E. Zino, Claudio Bordignon, Catia Traversari	2000	1
17	Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the geneMAGE-3 International Journal of Cancer ·Katharina Fleischhauer, Doriana Fruci, Peter Van Endert, Jean Herman, Silvia Tanzarella, 韩啸, Pierre G. Coulie, James Olayinka Adisa, Catia Traversari	1996	24
18	Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen‐specific immunotherapy International Journal of Cancer ·Vincenzo Russo, Catia Traversari, Alessandro Verrecchia, Marcella Mottolese, Pier Giorgio Natali, Fabien Mailhos	1995	70
19	Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics ·Etienne De Plaen, Catia Traversari, José J. Gaforio, Jean‐Pierre Szikora, Charles De Smet, Francis Brasseur, Pierre van der Bruggen, Bernard Lethé, Christophe Lurquin, Patrick Chomez, Olivier De Backer, Thierry Boon, Karen C. Arden, Webster K. Cavenee, Robert Brasseur Hit paper breakdown →	1994	513
20	Monoclonal Antibodies Against NIH 3T3 Cells Transformed by Human Thyroid Carcinoma DNA Hybridoma ·Rachele Alzani, Marco A. Pierotti, Sylvie Ménard, Silvana Canevari, Chisato Kimizu, Dario Ballinari, Catia Traversari, Gabriella Della Torre, Paolo Radice, Silvana Pilotti, Alfredo Fusco, Michèle Grieco, Giuseppe Della Porta, Maria I. Colnaghi	1988	1

About Catia Traversari

Catia Traversari is a scholar working on Immunology, Oncology, Immunology and Allergy, Genetics and Molecular Biology, having authored 109 papers that have together received 12.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (52 papers), Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (31 papers), CAR-T cell therapy research (26 papers), Virus-based gene therapy research (24 papers), RNA Interference and Gene Delivery (11 papers), vaccines and immunoinformatics approaches (10 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Immunology (8.3k citations), Oncology (5.5k citations), Genetics (2.2k citations), Molecular Biology (5.5k citations) and Hematology (780 citations). Catia Traversari has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include Thierry Boon, Pierre van der Bruggen, Christophe Lurquin, Etienne De Plaen, Patrick Chomez, Claudio Bordignon, Benoı̂t Van den Eynde, Alexander Knuth, Chiara Bonini and Vincenzo Russo. Their work appears in journals such as Blood, The Journal of Immunology, International Journal of Cancer, The Journal of Experimental Medicine and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact